Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 265

Similar articles for PubMed (Select 17057028)

1.

The epidemiology of second primary cancers.

Travis LB.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2020-6. Epub 2006 Oct 20. Review.

2.

[Secondary malignant neoplasms].

Tanaka R.

Nihon Rinsho. 2015 Feb;73 Suppl 2:524-7. Japanese. No abstract available.

PMID:
25831816
3.

Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.

Bhatia S.

Cancer. 2015 Mar 1;121(5):648-63. doi: 10.1002/cncr.29096. Epub 2014 Oct 29. Review.

PMID:
25355167
4.

Is there an increased risk of second primary malignancy after diagnosis of thyroid cancer?

Mathur A, Schneider EB, Zeiger MA.

Cancer. 2015 Jan 15;121(2):166-8. doi: 10.1002/cncr.29026. Epub 2014 Sep 15. No abstract available.

PMID:
25223812
5.

Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature.

Choi DK, Helenowski I, Hijiya N.

Int J Cancer. 2014 Oct 15;135(8):1764-73. doi: 10.1002/ijc.28991. Epub 2014 Jun 19. Review.

PMID:
24945137
6.

Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.

Lochhead P, Chan AT, Nishihara R, Fuchs CS, Beck AH, Giovannucci E, Ogino S.

Mod Pathol. 2015 Jan;28(1):14-29. doi: 10.1038/modpathol.2014.81. Epub 2014 Jun 13.

7.

[Prevention of risk of second primary neoplasms].

Warnet S.

Rev Infirm. 2014 Apr;200:8. French. No abstract available.

PMID:
24881229
8.

Pooling prospective studies to investigate the etiology of second cancers.

Black A, Gibson TM, Shiels MS, Park Y, Robien K, Albanes D, Weinstein SJ, Freeman LE, Andreotti G, Purdue MP, Fraumeni JF, Hartge P, Tucker MA, Hoover RN, Cerhan JR, Zeleniuch-Jacquotte A, Curtis RE, Elena J, Sampson JN, Berrington de Gonzalez A, Morton LM.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1598-608. doi: 10.1158/1055-9965.EPI-14-0191. Epub 2014 May 15.

PMID:
24832874
9.

Second primary cancers -  causes, incidence and the future.

Koubková L, Hrstka R, Dobes P, Vojtesek B, Vyzula R.

Klin Onkol. 2014;27(1):11-7.

PMID:
24635432
10.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

Health Phys. 2014 Feb;106(2):229-46. doi: 10.1097/HP.0000000000000013. Review.

PMID:
24378498
11.

Management of the late effects of treatments for gynecological cancer.

Andrews S, von Gruenigen VE.

Curr Opin Oncol. 2013 Sep;25(5):566-70. doi: 10.1097/CCO.0b013e328363e11a. Review.

PMID:
23942302
12.

Second cancers after childhood cancer--GPs beware!

Berendsen AJ, Groot Nibbelink A, Blaauwbroek R, Berger MY, Tissing WJ.

Scand J Prim Health Care. 2013 Sep;31(3):147-52. doi: 10.3109/02813432.2013.824152. Epub 2013 Aug 2.

13.

Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk.

Braunstein S, Nakamura JL.

Front Oncol. 2013 Apr 3;3:73. doi: 10.3389/fonc.2013.00073. eCollection 2013.

14.

Exercise therapy as treatment for cardiovascular and oncologic disease after a diagnosis of early-stage cancer.

Scott JM, Koelwyn GJ, Hornsby WE, Khouri M, Peppercorn J, Douglas PS, Jones LW.

Semin Oncol. 2013 Apr;40(2):218-28. doi: 10.1053/j.seminoncol.2013.01.001. Review.

PMID:
23540747
15.

Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.

Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK.

Nat Rev Clin Oncol. 2013 May;10(5):289-301. doi: 10.1038/nrclinonc.2013.41. Epub 2013 Mar 26. Review.

PMID:
23529000
16.

Childhood cancer survivorship: an update on evolving paradigms for understanding pathogenesis and screening for therapy-related late effects.

Armenian SH, Robison LL.

Curr Opin Pediatr. 2013 Feb;25(1):16-22. doi: 10.1097/MOP.0b013e32835b0b6a. Review.

17.

Managing the consequences of cancer treatment and the English National Cancer Survivorship Initiative.

Maher EJ.

Acta Oncol. 2013 Feb;52(2):225-32. doi: 10.3109/0284186X.2012.746467. Epub 2012 Dec 13. Review.

PMID:
23237053
18.

Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.

Elena JW, Travis LB, Simonds NI, Ambrosone CB, Ballard-Barbash R, Bhatia S, Cerhan JR, Hartge P, Heist RS, Kushi LH, Lash TL, Morton LM, Onel K, Pierce JP, Robison LL, Rowland JH, Schrag D, Sellers TA, Seminara D, Shu XO, Thomas NE, Ulrich CM, Freedman AN.

J Natl Cancer Inst. 2013 Jan 16;105(2):85-94. doi: 10.1093/jnci/djs473. Epub 2012 Nov 28. Review.

19.

Mode of primary cancer detection as an indicator of screening practice for second primary cancer in cancer survivors: a nationwide survey in Korea.

Suh B, Shin DW, Kim SY, Park JH, Chang WY, Lim SP, Yim CY, Cho BL, Park EC, Park JH.

BMC Cancer. 2012 Nov 26;12:557. doi: 10.1186/1471-2407-12-557.

20.

Risk of second cancers after photon and proton radiotherapy: a review of the data.

Yock TI, Caruso PA.

Health Phys. 2012 Nov;103(5):577-85. doi: 10.1097/HP.0b013e3182609ba4. Review.

PMID:
23032887
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk